Address
455 North Bernardo Avenue
Mountain View, CA 94043
United States of America (the)
Phone
650 237 2700
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
203
First IPO Date
April 22, 2021
| Name | Title | Pay | Year Born |
| Joel D. Becker | Chief Executive Officer, President & Director | 1.12M | 1968 |
| Rebecca L. Kuhn | Advisor | 588,399 | 1961 |
| Patrick F. Williams | Chief Financial Officer | 689,414 | 1973 |
| Martha J. Morrell | Chief Medical Officer | 725,315 | 1957 |
| Scott R. Schaper | Head of Investor Relations | 0 | N/A |
| Julie Hsu | Vice President & Controller | 0 | N/A |
| Chris Reese | Senior Vice President of Sales | 0 | N/A |
| Dylan John | Chief of Operations & Development | 0 | N/A |
| Amy Treadwell | Vice President of Human Resources | 0 | N/A |
| Katie Keller | Vice President of Marketing | 0 | N/A |
| Leah Akin | General Counsel & Corporate Secretary | 0 | N/A |
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.